(406) Axelopran phase 2B study demonstrates a sustained increase in bowel movement frequency in patients regardeless of duration of opioid-induced constipation

✍ Scribed by Vickery, R.; Webster, L.; Li, Y.; Singla, N.; Canafax, D.

• Book ID: 122728062
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 95 KB
• Volume: 15
• Category: Article
• ISSN: 1528-8447
• DOI: 10.1016/j.jpain.2014.01.317